Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Draft Conflict Of Interest Policy Affects Status Of Many FDA Cmte. Members

This article was originally published in The Tan Sheet

Executive Summary

A "significant fraction" of current FDA advisory committee members' eligibility to vote and participate in meetings would be affected by a revised conflict of interest policy, FDA said
Advertisement

Related Content

Advisory Committee Policy Allows Members With Financial Conflicts To Vote
Advisory Committee Vacancies Remain High As FDA Revs Up Search
Advisory Committees Free Of Conflicts May Be Unfeasible, FDA Review Says
FDA advisory committee changes
FDA Extends Conflict Disclosure Policy To All Advisory Panel Members
NIH gets conflict attention
FDA Aims To Boost Transparency Through Earlier Release Of Panel Materials
‘High Dollar’ Conflicts Should Nullify FDA Advisory Panelists – Public Citizen
FDA Waiver Of COX-2 Panel Conflicts Draws More Attention On The Hill
FDA Waiver Of COX-2 Panel Conflicts Draws More Attention On The Hill

Topics

Advertisement
UsernamePublicRestriction

Register

PS100334

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel